CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia

Nucleolar retention of a translational C/EBPα isoform stimulates rDNA transcription and cell size

(2010) Christine Müller et al.   EMBO JOURNAL

Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features

(2009) M. E. Figueroa et al.   BLOOD

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations

(2009) J.-L. Tang et al.   BLOOD

Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome

(2009) B. J. Wouters et al.   BLOOD

Reply to ‘Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis’

(2009) H-A Hou et al.   BRITISH JOURNAL OF CANCER

Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis

(2009) T Pabst et al.   BRITISH JOURNAL OF CANCER

Epigenetic Modification of CCAAT/Enhancer Binding Protein   Expression in Acute Myeloid Leukemia

(2008) B. Hackanson et al.   CANCER RESEARCH

Epigenetic regulation and molecular characterization of C/EBPα in pancreatic cancer cells

(2008) Takashi Kumagai et al.   INTERNATIONAL JOURNAL OF CANCER

Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

(2008) Richard F. Schlenk et al.   NEW ENGLAND JOURNAL OF MEDICINE